FOSHAN, China, Dec. 20, 2023 /PRNewswire/ — Bright Scholar Education Holdings Limited ("Bright Scholar" or the "Company") (NYSE: BEDU), a global premier education service company, today announced that it held its 2024 annual general meeting of shareholders on December 19, 2023. At the meeting, the shareholders resolved by ordinary resolutions to ratify the appointment of (1) Deloitte Touche Tohmatsu Certified Public Accountants LLP as the independent registered public accounting firm of the Company for the fiscal year ended August 31, 2023, (2) Mr. Hongru Zhou as a director and chairman of the board of directors of the Company (the "Board") and a member of the nominating and corporate governance committee and the compensation committee of the Company, and (3) Mr. Meng Rui as an independent director and the chairman of the audit committee of the Board.

About Bright Scholar Education Holdings Limited

Bright Scholar is a global premier education service company, which primarily provides quality international education to global students and equip them with the critical academic foundation and skillsets necessary to succeed in the pursuit of higher education.

IR Contact:Email: BEDU.IR@gcm.international 

Media Contact:Email: media@brightscholar.com Phone: +86-757-2991-6814

Source link

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
You May Also Like

Agibot Unveils Next-Gen Industrial-Grade Interactive Embodied Robot Agibot G2

SHANGHAI, Oct. 16, 2025 /PRNewswire/ — Today, Agibot officially launched its next-generation industrial-grade…

XPENG-Peking University Collaborative Research Accepted by AAAI 2026: Introducing a Novel Visual Token Pruning Framework for Autonomous Driving

XPENG-PKU Research Breakthrough: XPENG, in collaboration with Peking University, has developed FastDriveVLA—a…

GenEditBio Receives FDA Clearance of IND Application for Its Lead In Vivo Genome-Editing Program GEB-101 for TGFBI Corneal Dystrophy

HONG KONG, Jan. 5, 2026 /PRNewswire/ — GenEditBio Limited ("GenEditBio"), a clinical-stage…